Jan 11 (Reuters) - Resverlogix Corp:
* RESVERLOGIX RECEIVES FDA PROTOCOL ACCEPTANCE FOR THE ONGOING PHASE 3 BETONMACE TRIAL
* RESVERLOGIX CORP - BETONMACE TOP LINE DATA IS STILL PLANNED TO BE AVAILABLE AROUND END OF 2018
* RESVERLOGIX - BETONMACE TRIAL WILL NOW BE EXPANDED TO NORTH AMERICA Source text for Eikon: Further company coverage:
 